Press Releases
Alize Pharma launches the first Phase I clinical trial for AZP-531, its unacylated ghrelin analog, in type 2 diabetes
Alize Pharma, a company specialized in the development of drugs for the treatment of metabolic diseases and rare diseases, announces today the launch of the first Phase I clinical trial for AZP-531, its unacylated ghrelin analog, in type 2...
Press Releases
Impax Laboratories Launches Authorized Generic TRILIPIX® Delayed Release Capsules, 45 mg and 135 mg
Impax Laboratories Inc. today announced that it is commencing shipment of authorized generic TRILIPIX® (fenofibric acid) delayed release capsules 45 mg and 135 mg through Global Pharmaceuticals Impax’s generics division. Under the terms of a...
Press Releases
Tetrahedron announces that Selisseo(R) received a market authorization for use in animal nutrition
Tetrahedron, designing and developing rare natural and synthetic antioxidants for the health nutrition, dermocosmetics and pharmacy sectors, today announces that Selisseo(R) has received marketing authorization (MA) from the European Commission for use in animal nutrition for all animal species....
Press Releases
Medivir Streamlines Operations by Divesting Cross Pharma, its Parallel Import Business
Medivir AB (STO:MVIR-B) today announced that the company has signed an agreement to sell its wholly owned subsidiary Cross Pharma AB to Unimedic AB a subsidiary of the Swedish listed company MedCap AB. The intention is to close the...
Press Releases
Quintiles Named Britain’s Healthiest Large Company
Quintiles has been named “Britain’s Healthiest Large Company” in the first survey of its kind to identify organizations in Britain with outstanding employee health and wellness programs. Quintiles also received top honors as overall healthiest...
Press Releases
Obesity is a Disease: The American Medical Association Agrees with the American Association of Clinical Endocrinologists
The American Association of Clinical Endocrinologists (AACE) applauds the American Medical Association (AMA) House of Delegates for its action today to approve a resolution recognizing obesity as a disease state requiring a range of interventions to advance obesity treatment...
Press Releases
Preclinical program of translational research tasked with identifying new target proteins
Sanofi and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, today announce the establishment of a three-year research collaboration to identify new therapeutic targets for the development of treatments for ovarian cancer. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read